Joint Filer Information
| Name: | Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Management Company, L.P., Deerfield Private Design Fund III, L.P., Deerfield Private Design Fund IV, L.P. and Deerfield Healthcare Innovations Fund, L.P. |
| | |
| Address: | 780 Third Avenue, 37th Floor New York, NY 10017 |
| | |
| Designated Filer: | James E. Flynn |
| | |
| Issuer and Ticker Symbol: | Larimar Therapeutics, Inc. [LRMR] |
| | |
| Date of Event Requiring Statement: | March 28, 2020 |
The undersigned, Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Management Company, L.P., Deerfield Private Design Fund III, L.P., Deerfield Private Design Fund IV, L.P. and Deerfield Healthcare Innovations Fund, L.P. are jointly filing the attached Initial Statement of Beneficial Ownership on Form 3 with James E. Flynn with respect to the beneficial ownership of securities of Larimar Therapeutics, Inc.
Signatures:
DEERFIELD MGMT III, L.P. By: J.E. Flynn Capital III, LLC, General Partner By:/s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact | DEERFIELD PRIVATE DESIGN FUND III, L.P. By: Deerfield Mgmt III, L.P., General Partner By: J.E. Flynn Capital III, LLC, General Partner By:/s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact |
DEERFIELD MGMT IV, L.P. By: J.E. Flynn Capital IV, LLC, General Partner By:/s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact | DEERFIELD PRIVATE DESIGN FUND IV, L.P. By: Deerfield Mgmt IV, L.P., General Partner By: J.E. Flynn Capital IV, LLC, General Partner By:/s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact |
DEERFIELD MGMT HIF, L.P. By: J.E. Flynn Capital HIF, LLC, General Partner By:/s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact | DEERFIELD HEALTHCARE INNOVATIONS FUND, L.P. By: Deerfield Mgmt HIF, L.P., General Partner By: J.E. Flynn Capital HIF, LLC, General Partner By:/s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact |
DEERFIELD MANAGEMENT COMPANY, L.P. By: Flynn Management LLC, General Partner By:/s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact | |
